Absci Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Absci Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
No other changes.
No other changes.
No thesis.
+0.96%
vs ±14.9% implied · ×0.06
shaded = implied · ▲▼ = realized
Absci Corp
11.12
−0.98 · −8.10%
post 11.21 +0.81%
| Manager | Value | % base | |
|---|---|---|---|
| FMR | $294.5M | 16.48% | +12.68% |
| ARK | $149.8M | 8.38% | −5.83% |
| BlackRockindex-like | $141.1M | 7.90% | +8.17% |
| State Streetindex-like | $93.8M | 5.25% | +10.55% |
| Ameriprise Financial | $81.0M | 4.54% | +119.86% |
| Manager | Value | % base | |
|---|---|---|---|
| FMR | $294.5M | 16.48% | +12.68% |
| ARK | $149.8M | 8.38% | −5.83% |
| BlackRockindex-like | $141.1M | 7.90% | +8.17% |
| State Streetindex-like | $93.8M | 5.25% | +10.55% |
| Ameriprise Financial | $81.0M | 4.54% | +119.86% |
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; of Absci Corp's 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; of Absci Corp's 6 closest co-movers, none share that code.
Bull2
Bear1
Expected move
Inputsspot 11.13exp Nov 20ATM strike 11ATM straddle 2.47IV 117%